Innovative Care Pathway in Physical Activity and Behavior Change in Coronary Patients Post Cardiac Rehabilitation

Elsan0 sites192 target enrollmentMay 2024

ConditionsIndividualised Physical Activity Program Coronary Patient

Overview

Phase: N/A
Intervention: Not specified
Conditions: Individualised Physical Activity Program
Sponsor: Elsan
Enrollment: 192
Primary Endpoint: 6 minutes walk test
Status: Not Yet Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The objective of this 18-month research is to show the effectiveness of an individualized physical activity( PA) compared to standard PA management and voluntary PA, to achieve a change in the behavior of the coronary patient.

Registry

clinicaltrials.gov

Start Date

May 2024

End Date

November 2026

Last Updated

2 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Elsan

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Post-infarction coronary artery patient aged 18 years and older, with no gender difference.
•Patients engaged in a follow-up care and cardiovascular rehabilitation program at the Supervaltech center.
•Patient at low to moderate RARE risk of complication (RARE score 2 to 3)
•Patients equipped with smartphones, laptops or other equipment compatible with downloading an application with their personal ID
•Patient able to understand French for the purpose of conducting the study.
•Affiliated member or beneficiary of a social security scheme.
•Participant who has been informed and has given free, informed and written consent (no later than the day of inclusion and before any examination required by the research).

Exclusion Criteria

•Patients with a formal contraindication to physical activity such as: unstabilized coronary syndrome, decompensated heart failure, severe ventricular arrhythmias, intracardiac thrombus at risk embolic, PAH, moderate pericardial effusion, history of thrombophlebitis with or without pulmonary embolism, severe and/or symptomatic left ventricular ejection obstruction.
•Patients with ongoing infectious disease
•Participant whose physical and/or psychological health is severely impaired, which in the opinion of the investigator may affect the study participant's compliance.
•Participant included in other research
•Participant in a period of exclusion from another research still in progress at the time of inclusion.
•Protected participant: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
•Pregnant, breastfeeding or parturient women.
•Participant hospitalized without consent.